- 2016
-
Press releases - 07.07.2016
Can we suppress the antipsychotic drug side-effects?
Since their development in the 1950s, antipsychotic drugs have been widely used to treat psychoses and neuropsychiatric disorders like schizophrenia. A debilitating side-effect of these drugs called parkinsonism limits their efficacy.Irvine scientists led by Emiliana Borrelli, Inserm research director at University of California and colleagues have discovered the key cellular mechanism that underlies the antipsychotic-induced parkinsonism – which includes involuntary movements, tremors and other severe physical conditions. These studies present evidence that will stimulate a targeted approach for the design of novel antipsychotics without side-effects. The results have been published in Neuron on July, 6th.
-
News in brief - 07.07.2016
(Im)migration and Health
Many people are now arriving in France, after leaving their country of origin, fleeing war or extreme poverty. Whether they are migrants or immigrants, these populations are exposed to precarious circumstances and difficult living conditions. What does this mean for their health? The latest issue of Science & Santé magazine dedicates 2 pages to this subject: […]
-
Press releases - 06.07.2016
Very premature infants: towards better care
Born too soon, very premature infants are particularly vulnerable and need appropriate care. The European project EPICE (Effective Perinatal Intensive Care in Europe) examines how medical practices based on scientific evidence are incorporated into the care of these neonates[1]. The study, coordinated by Inserm and published in The British Medical Journal, highlights the underuse of four effective practices for improving their survival and long-term health, and estimates its impact on mortality and morbidity.
-
Press releases - 01.07.2016
How fatigue influences our decision-making
To resist the temptation of a beer in order to save and buy a bike later? At the end of the day, fatigue would encourage us to choose the immediate reward instead. This is what is revealed by a study published in PNAS and conducted by Bastien Blain, a researcher at Inserm Unit 1127.
-
What's on? - 01.07.2016
How fatigue influences our decision-making
To resist the temptation of a beer in order to save and buy a bike later? At the end of the day, fatigue would encourage us to choose the immediate reward instead. This is what is revealed by a study published in PNAS and conducted by Bastien Blain, a researcher at Inserm Unit 1127. Behavioural […]
-
Press releases - 01.07.2016
Yves Lévy, Chairman and CEO of Inserm, appointed member of the UN “Global Health Crises” Task Force
UN Secretary-General Mr Ban Ki-moon has just announced the creation of a “Global Health Crises” Task Force, which will bring together 3 co-leads and 12 members, including Inserm Chairman and CEO Yves Lévy. The Task Force will ensure the implementation and monitoring of the recommendations of the report, “Protecting humanity from future health crises,” submitted to the UN Secretary-General in February 2016 by the High-level Panel on the Global Response to Health Crises[1]. The main mission of the Task Force will be to alert the UN Secretary-General on matters related to emerging crises and any gaps or weaknesses in the world health system.
-
Press releases - 30.06.2016
Ethical issues surrounding CRISPR-Cas9 technology
On 13 June last, the Inserm Ethics Committee assembled over a hundred individuals at its annual seminar. All those present had the benefit of an ethical perspective on many problems posed by biomedical research. One of the questions addressed was that of CRISPR-Cas9 technology. The Ethics Committee has devoted a specific opinion to it, while the NIH has just obtained a first green light for a human cancer immunotherapy trial.
-
Press releases - 23.06.2016
Presentation of the French Plan for Genomic Medicine 2025
The French Plan for Genomic Medicine 2025 was presented to Prime Minister Manuel Valls by Yves Lévy, President of the National Alliance for Life Sciences and Health (Aviesan) and CEO of Inserm, on 22 June 2016.
-
Press releases - 16.06.2016
Brain tumours: for the first time, ultrasound makes blood vessels permeable to enhance treatment delivery
Teams from the Paris Public Hospitals (AP-HP), Pierre and Marie Curie University, Inserm and the CarThera company, coordinated by Prof. Alexandre Carpentier, have successfully used ultrasound to temporarily permeabilise blood vessels in the brains of patients affected by recurrent malignant brain tumours.
-
Press releases - 13.06.2016
A novel research program on traumatic memories
How will the traumatic events of the terrorist attacks of 13 November 2015 evolve in people’s memories, whether collective or individual? How does individual memory feed on collective memory and vice versa? Is it possible, by studying cerebral markers, to predict which victims will develop post-traumatic stress disorder and which will recover more quickly?